Characteristics | All participants n (%) | HIV-1 genotypes | χ2 | P value | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRF01_AE n (%) | CRF07_BC n (%) | CRF08_BC n (%) | C n (%) | CRF55_01B n (%) | Others* n (%) | |||||||||||||||
Overall | 1006(100) | 339(100) | 409(100) | 69(100) | 54(100) | 50(100) | 85(100) | Â | Â | |||||||||||
Gender | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||||||||||
Male | 868(86.3) | 298(87.9) | 366(89.5) | 50(72.5) | 42(77.8) | 47(94.0) | 65(76.5) | 25.799 | < 0.001 | |||||||||||
Female | 138(13.7) | 41(12.1) | 43(10.5) | 19(27.5) | 12(22.2) | 3(6.0) | 20(23.5) | Â | Â | |||||||||||
Age (years) | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||||||||||
< 25 | 139(13.8) | 50(14.7) | 63(15.4) | 5(7.2) | 3(5.6) | 7(14.0) | 11(12.9) | 51.906 | < 0.001 | |||||||||||
25~ | 356(35.4) | 130(38.3) | 149(36.4) | 14(20.3) | 20(37.0) | 25(50.0) | 18(21.2) | Â | Â | |||||||||||
40~ | 354(35.2) | 110(32.4) | 139(34.0) | 26(37.7) | 24(44.4) | 18(36.0) | 37(43.5) | Â | Â | |||||||||||
≥ 60 | 157(15.6) | 49(14.5) | 58(14.2) | 24(34.8) | 7(13.0) | 0(0) | 19(22.4) |  |  | |||||||||||
Marital status | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||||||||||
Single | 377(37.5) | 135(39.8) | 166(40.6) | 16(23.2) | 16(29.6) | 20(40.0) | 24(28.2) | 17.299 | 0.068 | |||||||||||
Married | 431(42.8) | 139(41.0) | 160(39.1) | 35(50.7) | 28(51.9) | 24(48.0) | 45(52.9) | Â | Â | |||||||||||
Divorce or death | 198(19.7) | 65(19.2) | 83(20.3) | 18(26.1) | 10(18.5) | 6(12.0) | 16(18.8) | Â | Â | |||||||||||
Education level | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||||||||||
Middle school or less | 622(61.8) | 208(61.4) | 242(59.2) | 57(82.6) | 35(64.8) | 22(44.0) | 58(68.2) | 22.299 | < 0.001 | |||||||||||
High school or above | 384(38.2) | 131(38.6) | 167(40.8) | 12(17.4) | 19(35.2) | 28(56.0) | 27(31.8) | Â | Â | |||||||||||
Nationality | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||||||||||
Han | 964(95.8) | 329(97.1) | 392(95.8) | 64(92.8) | 51(94.4) | 47(94.0) | 81(95.3) | 4.534 | 0.450 | |||||||||||
Others | 42(4.2) | 10(2.9) | 17(4.2) | 5(7.2) | 3(5.6) | 3(6.0) | 4(4.7) | Â | Â | |||||||||||
Location | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||||||||||
Local | 438(43.5) | 153(45.1) | 167(40.8) | 36(52.2) | 27(50.0) | 19(38.0) | 36(42.4) | 5.253 | 0.386 | |||||||||||
Non local | 568(56.5) | 186(54.9) | 242(59.2) | 33(47.8) | 27(50.0) | 31(62.0) | 49(57.6) | Â | Â | |||||||||||
Route of infection | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||||||||||
Heterosexual transmission | 532(52.7) | 185(54.6) | 193(47.2) | 56(81.2) | 33(61.1) | 17(34.0) | 48(56.5) | 42.681 | < 0.001 | |||||||||||
Homosexual transmission | 470(46.7) | 152(44.8) | 215(52.6) | 13(18.8) | 20(37.0) | 33(66.0) | 37(43.5) | Â | Â | |||||||||||
Others | 4(0.6) | 2(0.6) | 1(0.2) | 0(0) | 1(1.9) | 0(0) | 0(0) | Â | Â | |||||||||||
Number of sexual partners in a life time | Â | Â | ||||||||||||||||||
<6 | 800(79.5) | 270(79.6) | 327(80.0) | 52(75.4) | 44(81.5) | 37(74.0) | 70(82.4) | 4.921 | 0.896 | |||||||||||
6 ~ 10 | 130(12.9) | 45(13.3) | 50(12.2) | 9(13.0) | 6(11.1) | 10(20.0) | 10(11.8) |  |  | |||||||||||
≥11 | 76(7.6) | 24(7.1) | 32(7.8) | 8(11.6) | 4(7.4) | 3(6.0) | 5(5.9) |  |  | |||||||||||
CD4,cell/ul | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||||||||||
< 200 | 379(37.7) | 147(43.4) | 138(33.7) | 25(36.2) | 19(35.2) | 14(28.0) | 36(42.4) | 19.400 | 0.035 | |||||||||||
200~ | 525(52.2) | 161(47.5) | 236(57.7) | 32(46.4) | 30(55.6) | 29(58.0) | 37(43.5) | Â | Â | |||||||||||
≥ 500 | 102(10.1) | 31(9.1) | 35(8.6) | 12(17.4) | 5(9.3) | 7(14.0) | 12(14.1) |  |  | |||||||||||
Transmitted drug resistance | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||||||||||
Sensitive | 945(93.9) | 313(92.3) | 399(97.6) | 57(82.6) | 49(90.7) | 47(94.0) | 80(94.1) | 25.686 | < 0.001 | |||||||||||
Resistance | 61(6.1) | 26(7.7) | 10(2.4) | 12(17.4) | 5(9.3) | 3(6.0) | 5(5.9) | Â | Â |